Needham: Reiterates that Moderna (MRNA.US) holds the rating.
Zhitong FinanceApr 11 19:40
Moderna Analyst Ratings
BenzingaApr 11 19:36
Jefferies Investment Bank: Restated Moderna's (MRNA.US) rating, adjusted from buy to buy rating, target price $125.00.
Zhitong FinanceApr 10 00:20
Moderna Analyst Ratings
BenzingaApr 10 00:09
Jefferies Reiterates Buy on Moderna, Maintains $125 Price Target
BenzingaApr 10 00:11
Moderna Analyst Ratings
BenzingaMar 28 23:56
Moderna Analyst Ratings
BenzingaMar 28 17:45
Changes in US stocks | Moderna (MRNA.US) fell more than 4% after being downgraded by HSBC
Zhitong FinanceFeb 26 23:47
Moderna Analyst Ratings
BenzingaFeb 26 19:45
RBC Capital Reiterates Outperform on Moderna, Maintains $125 Price Target
BenzingaFeb 24 00:24
Canaccord Genuity Maintains Hold on Moderna, Raises Price Target to $91
BenzingaFeb 23 22:52
Moderna Analyst Ratings
BenzingaFeb 23 22:51
TD Cowen Maintains Market Perform Rating on Moderna Amid RSV Vaccine Concerns
InvestingFeb 9 05:02
Critical Insights From Moderna Analyst Ratings: What You Need To Know
BenzingaJan 13 01:00
RBC Capital Reiterates Outperform on Moderna, Maintains $125 Price Target
BenzingaJan 13 00:28
Moderna Analyst Ratings
BenzingaJan 13 00:27
Changes in US stocks | Moderna (MRNA.US) reversed the market and rose more than 10% to receive Oppenheimer's rating
Zhitong FinanceJan 2 23:11
Oppenheimer Lifts Moderna Rating on Key 2024/2025 Catalysts
InvestingJan 2 21:22
Moderna Analyst Ratings
BenzingaJan 2 20:42
Morgan Stanley Cuts Price Target on Moderna to $92 From $115, Keeps Equalweight Rating
MT NewswiresDec 12, 2023 21:05
No Data
No Data